<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>psilocybin therapy &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/psilocybin-therapy/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Mon, 05 Jan 2026 02:07:19 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>psilocybin therapy &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Psilocybin Therapy Shows Promise for Binge Eating Disorder</title>
		<link>https://bioengineer.org/psilocybin-therapy-shows-promise-for-binge-eating-disorder/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 05 Jan 2026 02:07:10 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Alternative mental health treatments]]></category>
		<category><![CDATA[Binge eating disorder]]></category>
		<category><![CDATA[pilot study outcomes]]></category>
		<category><![CDATA[psilocybin therapy]]></category>
		<category><![CDATA[Psychedelic research]]></category>
		<guid isPermaLink="false">https://bioengineer.org/psilocybin-therapy-shows-promise-for-binge-eating-disorder/</guid>

					<description><![CDATA[In a groundbreaking development within the field of mental health and dietary disorders, a team of researchers led by Dr. Dallery has embarked on an insightful exploration into the efficacy of psilocybin-assisted therapy specifically tailored for individuals grappling with binge eating disorder (BED). This pilot study, published in the Journal of Eating Disorders, provides a [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">313617</post-id>	</item>
		<item>
		<title>Reassessing Dissociated Memories During Psilocybin Therapy</title>
		<link>https://bioengineer.org/reassessing-dissociated-memories-during-psilocybin-therapy/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sun, 21 Dec 2025 11:33:05 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[ethical considerations in psychedelics]]></category>
		<category><![CDATA[memory reconstruction in trauma]]></category>
		<category><![CDATA[psilocybin therapy]]></category>
		<category><![CDATA[psychedelic-assisted psychotherapy]]></category>
		<category><![CDATA[traumatic memory retrieval]]></category>
		<guid isPermaLink="false">https://bioengineer.org/reassessing-dissociated-memories-during-psilocybin-therapy/</guid>

					<description><![CDATA[In a groundbreaking commentary published in “Journal of Eating Disorders,” researchers Kangaslampi and colleagues delve into a highly contentious topic within the realm of psychology and therapeutic practices— the recovery of dissociated traumatic memories during psilocybin treatment. This commentary serves as a critical examination of a recent study concerning the administration of psilocybin, a naturally [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">310039</post-id>	</item>
		<item>
		<title>Psilocybin Combined with Mindfulness Offers Hope for Treating Depression in Healthcare Workers</title>
		<link>https://bioengineer.org/psilocybin-combined-with-mindfulness-offers-hope-for-treating-depression-in-healthcare-workers/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 23 Oct 2025 22:31:35 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[COVID-19 mental health]]></category>
		<category><![CDATA[healthcare worker burnout]]></category>
		<category><![CDATA[mindfulness-based interventions]]></category>
		<category><![CDATA[psilocybin therapy]]></category>
		<category><![CDATA[psychedelic-assisted psychotherapy]]></category>
		<guid isPermaLink="false">https://bioengineer.org/psilocybin-combined-with-mindfulness-offers-hope-for-treating-depression-in-healthcare-workers/</guid>

					<description><![CDATA[In the wake of the COVID-19 pandemic, frontline healthcare workers have grappled with unprecedented levels of psychological distress, manifesting in widespread depression and burnout. Recognizing the urgent need for innovative therapeutic interventions, researchers at the Huntsman Mental Health Institute at University of Utah Health have conducted a pioneering study exploring the efficacy of combining psilocybin-assisted [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">286116</post-id>	</item>
		<item>
		<title>Single-Dose Psilocybin Eases Chronic Pain, Anxiety</title>
		<link>https://bioengineer.org/single-dose-psilocybin-eases-chronic-pain-anxiety/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 02 Oct 2025 11:08:46 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[anxiodepressive behaviors]]></category>
		<category><![CDATA[Chronic Pain Relief]]></category>
		<category><![CDATA[mouse models]]></category>
		<category><![CDATA[neuroplasticity mechanisms]]></category>
		<category><![CDATA[psilocybin therapy]]></category>
		<guid isPermaLink="false">https://bioengineer.org/single-dose-psilocybin-eases-chronic-pain-anxiety/</guid>

					<description><![CDATA[In a groundbreaking study published in Nature Neuroscience, researchers have unveiled compelling evidence that a single dose of psilocybin—a psychedelic compound found in certain species of mushrooms—can rapidly and durably alleviate both allodynia and anxiodepressive-like behaviors in mouse models of chronic pain. This discovery holds transformative potential for the future of pain management and psychiatric [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">274996</post-id>	</item>
	</channel>
</rss>
